2024 Annual Meeting | C10 - Myelin Oligodendrocyte Glycoprotein Antibody Disorders (MOGAD)

Date Saturday 04/13/24

Time 12:00 PM - 02:00 PM MDT Add To Calendar

Location Colorado Convention Center | Mile High 1EF

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Brenda Banwell, MD, FAAN

Topic(s) Multiple Sclerosis

Learning Objectives Participants will be presented with recently published international consensus diagnostic criteria for MOGAD, and details on laboratory testing for MOG-IgG. Clinical features, disease course, and current therapeutic strategies will be reviewed. MRI findings in MOGAD patients, as well as clues pointing towards other conditions in the differential of MOGAD, will be highlighted. Attendees will be provided an up-to-date review of the evolving landscape of MOGAD in both children and adults.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Fellow, Resident, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
12:00 PM - 12:05 PM MDT	Introduction	Welcome Brenda Banwell, MD, FAAN
12:05 PM - 12:40 PM MDT	Speaker	Clinical Features and Diagnosis of MOGAD Brenda Banwell, MD, FAAN
12:40 PM - 01:15 PM MDT	Speaker	Imaging Features of MOGAD and Key Flags Giulia Fadda, MD
01:15 PM - 01:45 PM MDT	Speaker	Pathological Insights into MOGAD Biology: Clues for Etiology and Treatment Romana Hoeftberger
01:45 PM - 02:00 PM MDT	Discussion	Panel and Audience Discussion on MOGAD: Future Directions Brenda Banwell, MD, FAAN

Faculty Disclosures
Brenda Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Giulia Fadda, MD	Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics.
Romana Hoeftberger	Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun, Biogen, Sanofi-Aventis, and UCB Biopharma.